Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
IL-17C is a functionally distinct member of the IL-17 family that binds IL-17 receptor E/A to promote innate defense in epithelial cells and regulate Th17 cell differentiation. We demonstrate that IL-17C (not IL-17A) is the most abundant IL-17 isoform in lesional psoriasis skin (1058 versus 8 pg/ml; p < 0.006) and localizes to keratinocytes (KCs), endothelial cells (ECs), and leukocytes. ECs stimulated with IL-17C produce increased TNF-α and KCs stimulated with IL-17C/TNF-α produce similar inflammatory gene response patterns as those elicited by IL-17A/TNF-α, including increases in IL-17C, TNF-α, IL-8, IL-1α/β, IL-1F5, IL-1F9, IL-6, IL-19, CCL20, S100A7/A8/A9, DEFB4, lipocalin 2, and peptidase inhibitor 3 (p < 0.05), indicating a positive proinflammatory feedback loop between the epidermis and ECs. Psoriasis patients treated with etanercept rapidly decrease cutaneous IL-17C levels, suggesting IL-17C/TNF-α-mediated inflammatory signaling is critical for psoriasis pathogenesis. Mice genetically engineered to overexpress IL-17C in KCs develop well-demarcated areas of erythematous, flakey involved skin adjacent to areas of normal-appearing uninvolved skin despite increased IL-17C expression in both areas (p < 0.05). Uninvolved skin displays increased angiogenesis and elevated S100A8/A9 expression (p < 0.05) but no epidermal hyperplasia, whereas involved skin exhibits robust epidermal hyperplasia, increased angiogenesis and leukocyte infiltration, and upregulated TNF-α, IL-1α/β, IL-17A/F, IL-23p19, vascular endothelial growth factor, IL-6, and CCL20 (p < 0.05), suggesting that IL-17C, when coupled with other proinflammatory signals, initiates the development of psoriasiform dermatitis. This skin phenotype was significantly improved following 8 wk of TNF-α inhibition. These findings identify a role for IL-17C in skin inflammation and suggest a pathogenic function for the elevated IL-17C observed in lesional psoriasis skin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-17C can drive psoriatic inflammation in mouse models”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Johnston et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Mease, P. J., Goffe, B. S., Metz, J., VanderStoep, A., Finck, B., & Burge, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02530-7 · Cited by 1,446
Functional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08769.x · Cited by 804
Chiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686
IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
Ramirez-Carrozzi, V., Sambandam, A., Luis, E., Lin, Z., Jeet, S., Lesch, J., Hackney, J., Kim, J., Zhou, M., Lai, J., et al. (2011) · Nature Immunology · doi:10.1038/ni.2156 · Cited by 477
A Randomized Trial of Etanercept as Monotherapy for Psoriasis
Gottlieb, A. B. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.12.1627 · Cited by 470
Research works printed but not linked: 1
- Russell CB Kerkof K Bigler J Timour M Diaz RL Symons A Rand H Krueger JG Martin DA IL-17 Receptor A subunit is a central hub for inflammatory signaling in human psoriasis Journal of Investigative Dermatology 2012 132 S7
Cited by
Items 101–200 of 309
Cytokines of the IL‐17 family in psoriasis
Lauffer, F., Eyerich, K., Boehncke, W., Asadullah, K., Beissert, S., Ghoreschi, K., & Schön, M. P. (2020) · JDDG: Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14124 · Cited by 51
Lundberg, K. C., Fritz, Y., Johnston, A. W. B., Foster, A. M., Baliwag, J., Gudjonsson, J. E., Schlatzer, D., Gokulrangan, G., McCormick, T. S., Chance, M. R., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.042242 · Cited by 51
Self-citationYan, D., Gudjonsson, J. E., Le, S. T., Maverakis, E., Plazyo, O., Ritchlin, C. T., Scher, J. U., Gangwar, R. S., Ward, N. L., Bell, S. J., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.02.764 · Cited by 62
Self-citationKurschus, F. C., & Moos, S. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.06.010 · Cited by 59
IL-17E (IL-25) and IL-17A Differentially Affect the Functions of Human Keratinocytes
Borowczyk, J., Buerger, C., Tadjrischi, N., Drukała, J., Wolnicki, M., Wnuk, D., Modarressi, A., Boehncke, W., & Brembilla, N. C. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.12.013 · Cited by 55
From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment
Vidal, S., Puig, L., Carrascosa, J. M., González‐Cantero, Á., Ruiz‐Carrascosa, J., & Velasco-Pastor, A.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136740 · Cited by 48
Butcher, M. J., Waseem, T. C., & Galkina, E. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307892 · Cited by 46
Advances in understanding of Netherton syndrome and therapeutic implications
Petrova, E., & Hovnanian, A. (2020) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2020.1857724 · Cited by 51
Distinctive expression pattern of interleukin-17 cytokine family members in colorectal cancer
Al‐Samadi, A., Moossavi, S., Salem, A., Sotoudeh, M., Tuovinen, S. M., Konttinen, Y. T., Salo, T. A., & Bishehsari, F. (2015) · Tumor Biology · doi:10.1007/s13277-015-3941-x · Cited by 48
Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases
Sullivan, G. P., Henry, C. M., Clancy, D. M., Mametnabiev, T. E., Belotcerkovskaya, E., Davidovich, P. B., Sura‐Trueba, S., Garabadzhiu, A. V., & Martin, S. J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0385-4 · Cited by 49
Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer
Meehan, E. V., & Wang, K. (2022) · Genes · doi:10.3390/genes13091643 · Cited by 51
Interleukin-17D Promotes Pathogenicity During Infection by Suppressing CD8 T Cell Activity
Lee, Y., Clinton, J., Yao, C., & Chang, S. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01172 · Cited by 43
CCL 7 contributes to the TNF ‐alpha‐dependent inflammation of lesional psoriatic skin
Brunner, P. M., Glitzner, E., Reininger, B., Klein, I., Stary, G., Mildner, M., Uhrín, P., Sibilia, M. C., & Stingl, G. (2015) · Experimental Dermatology · doi:10.1111/exd.12709 · Cited by 42
Russell, S. E., Stefanska, A. M., Kubica, M., Horan, R. M., Mantovani, A., Garlanda, C., Fallon, P. G., & Walsh, P. T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300828 · Cited by 44
Hashiguchi, Y., Yabe, R., Chung, S.-H., Murayama, M. A., Yoshida, K., Matsuo, K., Kubo, S., Saijo, S., Nakamura, Y., Matsue, H., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701157 · Cited by 42
RETRACTED: Multiple strategies with the synergistic approach for addressing colorectal cancer
Karthika, C., Hari, B., Rahman, M. H., Akter, R., Najda, A., Albadrani, G. M., Sayed, A. A., Akhtar, M. F., & Abdel‐Daim, M. M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111704 · Cited by 43
RetractedOntong, J. C., Lambert, S., Furnholm, T., Roberts, L., Reingold, L. J., Auepemkiate, S., Voravuthikunchai, S. P., & Johnston, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205340 · Cited by 42
Self-citationLangley, R. G. B., Armstrong, A. W., Lebwohl, M., Blauvelt, A., Hsu, S., Tyring, S. K., Rastogi, S., Pillai, R., & Israel, R. J. (2018) · British Journal of Dermatology · doi:10.1111/bjd.17318 · Cited by 39
IL-17C has a pathogenic role in kidney ischemia/reperfusion injury
Wang, F., Yin, J., Lin, Y., Zhang, F., Liu, X., Zhang, G., Kong, Y., Lu, Z., Wu, R., Wang, N., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.01.015 · Cited by 39
Abdelnabi, M. N., Hassan, G. S., & Shoukry, N. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1437046 · Cited by 46
Interleukin 6 regulates psoriasiform inflammation–associated thrombosis
Wang, Y., Golden, J. B., Fritz, Y., Zhang, X., Diaconu, D., Camhi, M. I., Gao, H., Dawes, S. M., Xing, X., Ganesh, S. K., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89384 · Cited by 40
Self-citationRitzmann, F., Jungnickel, C., Vella, G., Kamyschnikow, A., Herr, C., Li, D., Menger, M. M., Angenendt, A., Hoth, M., Lis, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46759-8 · Cited by 43
Defrêne, J., Berrazouane, S., Esparza, N., Pagé, N., Côté, M., Gobeil, S., Aoudjit, F., & Tessier, P. A. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000087 · Cited by 40
Wu, J., Li, H., & Li, M. (2015) · PubMed Central · Cited by 37
Akram, M., Kim, K.-A., Kim, E. S., Shin, Y., Noh, D., Kim, E., Kim, J., Majid, A., Chang, S., Kim, J., et al. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.029 · Cited by 42
Radiation-Induced Dermatitis is Mediated by IL17-Expressing γδ T Cells
Liao, W., Hei, T. K., & Cheng, S. K. (2017) · Radiation Research · doi:10.1667/rr007cc.1 · Cited by 38
Inuwa, I. M., Taranikanti, V., Al‐Rawahy, M., & Habbal, O. (2011) · Sultan Qaboos University medical journal · doi:10.18295/2075-0528.1298 · Cited by 45
Brodalumab for the treatment of plaque psoriasis: up-to-date
Beck, K. M., & Koo, J. Y. M. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1579794 · Cited by 36
Synergistic induction of IL-23 by TNFα, IL-17A, and EGF in keratinocytes
Ehst, B. D., Wang, Z., Leitenberger, J. J., McClanahan, D. R., Torre, R. D. L., Sawka, E., Ortega‐Loayza, A. G., Strunck, J. L., Greiling, T. M., Simpson, E. L., et al. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155357 · Cited by 37
Exacerbation of Allergen-Induced Eczema in TLR4- and TRIF-Deficient Mice
Brandt, E. B., Gibson, A. M., Bass, S. A., Rydyznski, C. E., & Hershey, G. K. K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300789 · Cited by 37
Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis
Peng, C., Zhang, S., Li, L., Zhang, X., Jia, X., Luo, Z., Huang, X., Kuang, Y., Zeng, W., Su, J., et al. (2017) · Scientific Reports · doi:10.1038/srep44172 · Cited by 37
Singh, S., & Awasthi, R. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104548 · Cited by 40
Paradoxical skin lesions induced by anti-TNF-α agents in SAPHO syndrome
Li, C., Wu, X., Cao, Y., Zeng, Y., Zhang, W., Zhang, S., Liu, Y., Jin, H., Zhang, W., & Li, L. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4083-5 · Cited by 32
IL-17C in human mucosal immunity: More than just a middle child
Swedik, S. M., Madola, A., & Levine, A. D. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155641 · Cited by 36
Interleukin-17C in Human Helicobacter pylori Gastritis
Tanaka, S., Nagashima, H., Cruz, M., Uchida, T., Uotani, T., Abreu, J. A. J., Mahachai, V., Vilaichone, R., Ratanachu‐ek, T., Tshering, L., et al. (2017) · Infection and Immunity · doi:10.1128/iai.00389-17 · Cited by 29
Interleukin-17 receptor D (Sef) is a multi-functional regulator of cell signaling
Pande, S., Yang, X., & Friesel, R. E. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-020-00695-7 · Cited by 31
Interventions in cytokine signaling: novel horizons for psoriasis treatment
Li, L., Liu, J., Lu, J., Wu, J., Zhang, X., Ma, T., Wu, X., Zhu, Q., Chen, Z., & Tai, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1573905 · Cited by 39
Interleukin-17: Functional and Structural Features, Application as a Therapeutic Target
Kostareva, O. S., Gabdulkhakov, A. G., Kolyadenko, I., Garber, M., & Tishchenko, S. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919140116 · Cited by 36
Mitochondrial Sirtuins in Skin and Skin Cancers
Su, S., Ndiaye, M. A., Singh, C. K., & Ahmad, N. (2020) · Photochemistry and Photobiology · doi:10.1111/php.13254 · Cited by 29
Wang, X., Kaiser, H., Kvist‐Hansen, A., McCauley, B. D., Skov, L., Hansen, P. R., & Becker, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010555 · Cited by 34
Miura, S., Garcet, S., Li, X., Cueto, I., Salud-Gnilo, C., Kunjravia, N., Yamamura, K., Gonzalez, J., Murai‐Yamamura, M., Rambhia, D., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.10.017 · Cited by 33
Tsoi, L. C., Xing, X., Xing, E., Wasikowski, R., Shao, S., Zeng, C., Plazyo, O., Kirma, J., Jiang, Y., Billi, A. C., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.09.038 · Cited by 29
Self-citationWilliams, S. C., Garcet, S., Hur, H. B., Miura, S., Gonzalez, J., Navrazhina, K., Murai‐Yamamura, M., Yamamura, K., Li, X., Frew, J. W., et al. (2024) · Experimental Dermatology · doi:10.1111/exd.15087 · Cited by 31
Chronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine models
Golden, J. B., Wang, Y., Fritz, Y., Diaconu, D., Zhang, X., Debanne, S. M., Simon, D. I., McCormick, T. S., & Ward, N. L. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0738-z · Cited by 29
Self-citationPiazza, S., Martinelli, G., Magnavacca, A., Fumagalli, M., Pozzoli, C., Terno, M., Canilli, L., Angarano, M., Maranta, N., Dell’Agli, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169279 · Cited by 32
The roles of IL-17C in T cell-dependent and -independent inflammatory diseases
Yamaguchi, S., Nambu, A., Numata, T., Yoshizaki, T., Narushima, S., Shimura, E., Hiraishi, Y., Arae, K., Morita, H., Matsumoto, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34054-x · Cited by 31
Atopic Dermatitis and Psoriasis: Similarities and Differences in Metabolism and Microbiome
Chen, Y., Peng, C., Zhu, L., Wang, J., Cao, Q., Chen, X., & Li, J. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-08995-3 · Cited by 29
Interleukin-19 as a translational indicator of renal injury
Jennings, P., Crean, D., Aschauer, L., Limonciel, A., Mönks, K., Kern, G., Hewitt, P. G., Lhotta, K., Lukas, A., Wilmes, A., et al. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1237-3 · Cited by 27
Kanda, T., Nishida, A., Takahashi, K., Hidaka, K., Imaeda, H., Inatomi, O., Bamba, S., Sugimoto, M., & Andoh, A. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00069 · Cited by 40
Wang, P., Killeen, M. E., Sumpter, T. L., Ferris, L. K., Falo, L. D., Freeman, B. Α., Schopfer, F. J., & Mathers, A. R. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101987 · Cited by 27
Interleukin-19 as an Immunoregulatory Cytokine
Fujimoto, Y., Kuramoto, N., Yoneyama, M., & Azuma, Y. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200424151528 · Cited by 29
Strunck, J. L., Cutler, B. R., Rajpal, B., Kent, G., Haynes, D., Topham, C. A., Ortega‐Loayza, A. G., Yang, D. Y., Wang, Z., Liu, Y., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.06.009 · Cited by 26
Mohan, G. C., Zhang, H., Bao, L., Many, B. T., & Chan, L. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173981 · Cited by 25
Sevimoğlu, T., Turanlı, B., Bereketoğlu, C., Arğa, K. Y., & Karadağ, A. S. (2018) · Gene · doi:10.1016/j.gene.2018.01.033 · Cited by 28
Miura, S., Garcet, S., Salud-Gnilo, C., Gonzalez, J., Li, X., Murai‐Yamamura, M., Yamamura, K., Rambhia, D., Kunjravia, N., Guttman‐Yassky, E., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.01.019 · Cited by 24
An update on emerging immunological targets and their inhibitors in the treatment of psoriasis
Parab, S. B., & Doshi, G. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109341 · Cited by 30
Eczematized psoriasis – a frequent but often neglected variant of plaque psoriasis
Lauffer, F., & Eyerich, K. (2023) · JDDG: Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14991 · Cited by 24
The safety of brodalumab for the treatment of psoriasis
Iznardo, H., & Puig, L. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1730326 · Cited by 26
Endres, C. J., Salinger, D. H., Köck, K., Gastonguay, M. R., Martin, D. A., Klekotka, P. A., Nirula, A., & Gibbs, M. A. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.334 · Cited by 26
Altieri, A., Piyadasa, H., Hemshekhar, M., Osawa, N., Recksiedler, B., Spicer, V., Hiemstra, P. S., Halayko, A. J., & Mookherjee, N. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00323-w · Cited by 24
Gouin, O., Barbieux, C., Leturcq, F., Claustres, M. B. D., Petrova, E., & Hovnanian, A. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.10.026 · Cited by 22
Clinical Efficacy and Safety of Ixekizumab for Treatment of Psoriasis
Azevedo, A., & Torres, T. R. (2016) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2016.09.021 · Cited by 24
Reactive Oxygen Species in Psoriasis and Psoriasis Arthritis: Relevance to Human Disease
Khmaladze, I., Nandakumar, K. S., & Holmdahl, R. (2015) · International Archives of Allergy and Immunology · doi:10.1159/000375401 · Cited by 27
Advances in Psoriasis Research: Decoding Immune Circuits and Developing Novel Therapies
Wang, L., Liu, R., Tang, Y.-L., Ma, Y.-F., Wang, G., Ruan, Q., & Zheng, S. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189233 · Cited by 33
The Experimental Animal Models in Psoriasis Research: A Comprehensive Review
Parab, S. B., & Doshi, G. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109897 · Cited by 23
Pandit, A. A., Gandham, R. K., Mukhopadhyay, C. S., Verma, R., & Sethi, R. S. (2019) · Respiratory Research · doi:10.1186/s12931-019-0986-1 · Cited by 21
Dai, Y., Xu, J., Gong, X., Wei, J., Gao, Y., Chai, R., Lu, C., Zhao, B. T., & Kang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020886 · Cited by 22
Murine models of psoriasis and its applications in drug development
Luo, T., Ma, Y., & Wei, W. (2019) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2019.106657 · Cited by 21
Boonpethkaew, S., Meephansan, J., Jumlongpim, O., Tangtanatakul, P., Soonthornchai, W., Wongpiyabovorn, J., Vipanurat, R., & Komine, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094983 · Cited by 19
Asahina, A., Okubo, Y., Morita, A., Tada, Y., Igarashi, A., Langley, R. G. B., Deherder, D., Matano, M., Vanvoorden, V., Wang, M., et al. (2023) · Dermatology and Therapy · doi:10.1007/s13555-022-00883-y · Cited by 20
Strober, B. E., Alikhan, A., Lockshin, B., Shi, R., Cirulli, J., & Schafer, P. H. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.09.003 · Cited by 21
IFN-κ Is a Rheostat for Development of Psoriasiform Inflammation
Gharaee‐Kermani, M., Estadt, S. N., Tsoi, L. C., Wolf, S., Liu, J. J., Xing, X., Theros, J. S., Reed, T. J., Lowe, L., Gruszka, D., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.05.029 · Cited by 23
Self-citationIsraël, L., Bardet, M., Huppertz, A., Mercado, N., Ginster, S., Unterreiner, A., Schlierf, A., Goetschy, J. F., Zerwes, H.-G., Roth, L., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.03.1503 · Cited by 18
Sigurgrímsdóttir, H., Björnsdóttir, E. Ö., Eysteinsdóttir, J. H., Ólafsson, J., Sigurgeirsson, B., Agnarsson, B. A., Einarsdottir, H., Freysdóttir, J., & Ludviksson, B. R. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13096 · Cited by 18
Yamanaka, K., Fujisawa, T., Kusagaya, H., Mori, K., Niwa, M., Furuhashi, K., Kono, M., Hamada, E., Suda, T., & Maekawa, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.207 · Cited by 17
Csősz, É., Tóth, N., Deák, E., Csutak, A., & Tőzsér, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124096 · Cited by 20
Immunopathogenesis of Psoriasis
Meglio, P. D., & Nestle, F. O. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_21 · Cited by 24
Zheng, T., Deng, J., Wen, J., Xiao, S., Huang, H., Shang, J., Zhang, L., Chen, H., Li, J., Wang, Y., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06700-w · Cited by 23
Zhang, M., Liu, J., Gao, R., Hu, Y., Lü, L., Liu, C., Ai, L., Pan, J., Tian, L., & Fan, J. J. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155630 · Cited by 19
IL-17C expression in nasal epithelial cells of chronic rhinosinusitis with nasal polyposis
Jin, J., Rha, K., Kim, D. W., & Kim, Y. M. (2013) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-013-2683-x · Cited by 17
Chiricozzi, A., SIMONE, C. D., Fossati, B., & Peris, K. (2019) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s179283 · Cited by 20
The Danger Model Approach to the Pathogenesis of the Rheumatic Diseases
Pacheco‐Tena, C., & González‐Chávez, S. A. (2015) · Journal of Immunology Research · doi:10.1155/2015/506089 · Cited by 18
Jiang, Y., Gruszka, D., Zeng, C., Swindell, W. R., Gaskill, C. F., Sorensen, C., Brown, W., Gangwar, R. S., Tsoi, L. C., Webster, J., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.172764 · Cited by 20
Self-citationGarcia, E. M., Lenz, J. D., Schaub, R. E., Hackett, K. T., Salgado‐Pabón, W., & Dillard, J. P. (2024) · Nature Communications · doi:10.1038/s41467-024-48141-3 · Cited by 20
Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly
Mylle, S., Grine, L., Speeckaert, R., Lambert, J., & van Geel, N. (2018) · American Journal of Clinical Dermatology · doi:10.1007/s40257-018-0366-5 · Cited by 16
Osteopontin and adiponectin: how far are they related in the complexity of psoriasis?
Kadry, D. M., Hegazy, R. A., & Rashed, L. A. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1392-z · Cited by 19
Davydova, A., Kurochkina, Y. D., Goncharova, V. E., Vorobyeva, M., & Korolev, M. A. (2023) · Biomedicines · doi:10.3390/biomedicines11051328 · Cited by 16
The Involvement of Serum Amyloid A in Psoriatic Inflammation
Morizane, S., Mizuno, K., Takiguchi, T., Sugimoto, S., & Iwatsuki, K. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.10.016 · Cited by 16
Kong, J., Sai, H., Crissey, M. A. S., Jhala, N. C., Falk, G. W., Ginsberg, G. G., Abrams, J. A., Nakagawa, H., Wang, K., Rustgi, A. K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5431 · Cited by 14
Lu, Y., Chen, H., Zhang, J., Tang, B., Zhang, H., Ma, C., Tang, X., Li, L., Wu, J., Wei, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.650816 · Cited by 14
Chandrasekharan, U. M., Kaur, R., Harvey, J. E., Braley, C., Rai, V., Lee, M., de Windt, N., Hsieh, J. K., Jaini, R., Bayık, D., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.12.036 · Cited by 14
Li, Y., Stoll, S. W., Sekhon, S., Talsma, C. E., Camhi, M. I., Jones, J. L., Lambert, S., Marley, H., Rittié, L., Grachtchouk, M. A., et al. (2015) · Experimental Dermatology · doi:10.1111/exd.12886 · Cited by 15
Self-citationIdentification of genes differentially expressed in menstrual breakdown and repair
Paiva, P., Lockhart, M. G., Girling, J. E., Olshansky, M., Woodrow, N. L., Marino, J. L., Hickey, M., & Rogers, P. A. W. (2016) · Molecular Human Reproduction · doi:10.1093/molehr/gaw060 · Cited by 14
Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis
Vu, T. T., Gooderham, M., & Papp, K. A. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1242409 · Cited by 14
Gradual development of psoriatic skin lesions by constitutive low-level expression of IL-17A
Wohn, C., Brand, A., van Ettinger, K., Brouwers-Haspels, I., Waisman, A., Laman, J. D., & Clausen, B. E. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.11.006 · Cited by 15
Aşkun, T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100869 · Cited by 16
Proteomic and Metabolomic Changes in Psoriasis Preclinical and Clinical Aspects
Radulska, A., Pelikant‐Małecka, I., Jendernalik, K., Dobrucki, I. T., & Kalinowski, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119507 · Cited by 14
Wu, X., Song, J., Zhang, Y., Kuai, L., Liu, C., Ma, X., Li, B., Zhang, Z., & Luo, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112244 · Cited by 13
Thaçi, D., Singh, D., Lee, M. S., Timmis, H., Jacobs, D., Passier, P. C. C. M., Rohrer, S., Beetens, J. R., Phung, D., Sondag, E., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237244 · Cited by 14
Ixekizumab for treatment of psoriasis
Dyring‐Andersen, B., Skov, L., & Zachariae, C. O. C. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1023295 · Cited by 12
Metadata
- Authors
- Johnston, A., Fritz, Y., Dawes, S. M., Diaconu, D., Al-Attar, P. M., Guzman, A. M., Chen, C. S., Fu, W., Gudjonsson, J. E., McCormick, T. S., & Ward, N. L.
- Affiliations
- University of Michigan (US)
- Case Western Reserve University (US)
- University Hospitals of Cleveland (US)
- Corresponding author
- Johnston, Andrew
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-01
- Volume
- 190
- Issue
- 5
- Pages
- 2252-2262
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3577967
- OpenAlex
- W2121900420
- Cited by
- 308
- References
- 37
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 20 · 2023: 22 · 2022: 25 · 2021: 36 · 2020: 29 · 2019: 23 · 2018: 29 · 2017: 24 · 2016: 24 · 2015: 23 · 2014: 19 · 2013: 7
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P50AR055508, P30AR039750, P50AR05508, P30 AR39750, R01AR062546, R01AR063437, K08AR060802)
- Janssen Research and Development
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- Keywords
- IL-17C, psoriasis, keratinocytes, IL-17A, TNF-α, endothelial cells, epidermal hyperplasia, angiogenesis, S100A8/A9, Th17 cells, IL-23, etanercept, anti-TNF therapy, psoriasiform dermatitis
- MeSH terms
- Etanercept, Adolescent, Adult, Aged, Animals, Anti-Inflammatory Agents, Non-Steroidal, Humans, Immunoglobulin G, Inflammation, Mice, Transgenic, Middle Aged, Psoriasis, Skin, Tumor Necrosis Factor-alpha, Signal Transduction, Keratinocytes, Gene Expression, Receptors, Tumor Necrosis Factor, Interleukin-17, Endothelial Cells, Mice, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.